Moleculera Biosciences Press Releases

Published on October 30, 2024 - 12:15 GMT

Moleculera Biosciences Awarded $500K Grant to Clinically Validate Immune-mediated Cardiovascular Disorder Biomarkers

Precision medicine blood panel to aid in diagnosing and treating patients with myocarditis, cardiomyopathy, and chronic heart failure due to immune dysfunction OKLAHOMA CITY, OK, UNITED STATES, October 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc. has won a $500,000 matching grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST) to support the development and clinical validation of a blood test panel for the company’s Autoimmune Cardiovascular Panel™. …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 10, 2024 - 12:00 GMT

Moleculera Biosciences welcomes Asad Hussain as Board Advisor on Strategic Finance

Appointment will help company drive financial performance, enhance operational efficiencies, and support long-term growth objectives OKLAHOMA CITY, OK, UNITED STATES, September 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, a precision medicine company focused on uncovering the immune-mediated roots of chronic central nervous system (CNS) and cardiovascular disorders, is pleased to announce the appointment of Asad Hussain as Board Advisor on Strategic Finance. Mr. Hussain brings more than 25 …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 22, 2024 - 12:00 GMT

Moleculera Biosciences Names B. Robert Mozayeni, MD as Medical and Clinical Advisor

Appointment will provide strategic guidance and insights as the company expands scope of work for immune-mediated disorders OKLAHOMA CITY, OK, USA, August 22, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused on uncovering the immune-mediated roots of chronic central nervous system (CNS) and cardiovascular disorders, has named B. Robert Mozayeni, MD, to its Board of Advisors as Medical and Clinical Advisor. Trained in Rheumatology and Internal Medicine at Yale …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 30, 2024 - 12:15 GMT

Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors

Rebrand aligns with precision medicine messaging for growth and expansion into additional immune-mediated disorder markets OKLAHOMA CITY, OK, USA, July 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, a precision medicine company focused on uncovering the immune-mediated roots of chronic central nervous system (CNS) and cardiovascular disorders, is pleased to announce it has rebranded to Moleculera Biosciences to more accurately reflect the company’s expanded scope of research and product offerings. …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 10, 2024 - 12:00 GMT

Moleculera Biosciences Names Dr. Safedin Sajo Beqaj as Clinical Laboratory Advisor

Appointment strengthens Company's Scientific and Clinical Board of Advisors as it continues to expand scope of its personalized medicine business OKLAHOMA CITY, OK, USA, July 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company, has named Safedin Sajo Beqaj, Ph.D., as Clinical Laboratory Advisor. Dr. Beqaj brings vast experience and expertise in areas of medical research, laboratory operations, teaching, molecular diagnostics and business management to the Company …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 23, 2024 - 14:15 GMT

Moleculera Biosciences Board of Directors names Healthcare Innovator and Leader Dr. Vijay Aggarwal as Board Chair

OKLAHOMA CITY, OK, UNITED STATES, May 23, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused on identifying and directing treatment for immune-mediated CNS and cardiovascular disorders, has appointed long-time healthcare innovator and leader Vijay Aggarwal, Ph.D., as Chairman of its Board of Directors. Dr. Aggarwal brings more than four decades of management experience in pharmaceutical services, diagnostics, and medical devices to the Board Chair position. …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 17, 2024 - 13:15 GMT

Moleculera Labs Forms Strategic Collaboration with Quest Diagnostics

Companies Collaborate to Broaden Access to Moleculera's Novel Neuropsychiatric Autoantibody Testing OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 17, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc, a precision medicine company pioneering immune-mediated neuropsychiatric testing, today announced a strategic collaboration with Quest Diagnostics (DGX: NYSE), the nation’s leading provider of diagnostic information services, to offer patients of Moleculera Labs’ neuropsychiatric autoantibody test …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 11, 2024 - 13:15 GMT

Moleculera Labs, Inc., Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm

Company leveraging strategic alliance w/OKC-based General Genomics to build next-gen predictive treatment model for immune-mediated neuropsychiatric disorders OKLAHOMA CITY, OK, UNITED STATES, January 11, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc., an Oklahoma City-based personalized medicine company, is the recipient of a matching Oklahoma Applied Research Support (OARS) grant of $500,000 over two years from the Oklahoma Center for the Advancement of Science and Technology (OCAST). The competitive …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 3, 2024 - 13:00 GMT

Moleculera Labs Names Healthcare Industry Veteran Rodney Cotton to Board of Directors

Company readies for growth and expansion of its business to identify and improve chronic immune-mediated disorders OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 3, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc., an Oklahoma City-based personalized medicine diagnostic company, welcomes Rodney Cotton to its Board of Directors. Cotton, a former Senior Vice President at Roche Diagnostics, brings 40-plus years of experience in the life science field to Moleculera’s Board. The appointment comes as the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

The Newsroom of Moleculera Biosciences